Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3764399015 | Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3764400010 | Ganciclovir 4.5 mg prolonged-release ocular implant | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) | Is a | Product containing ganciclovir | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) | Has active ingredient | Ganciclovir | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) | Is a | Product containing ganciclovir in ophthalmic dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) | Has manufactured dose form | Ocular dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) | Has manufactured dose form | Prolonged-release ocular implant | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) | Has precise active ingredient | Ganciclovir | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) | Has presentation strength numerator value | 4.5 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) | Has basis of strength substance | Ganciclovir | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) | Has unit of presentation | Implant | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) | Is a | Product containing only ganciclovir in ocular dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) | Has presentation strength denominator unit | Implant | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) | Plays role | Antiviral therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR